Market Place
Sourcing Support
Introducing Vicrista® – A New Era in Pediatric Oncology
03 Nov 2024 //
PRESS RELEASE
Ibrutinib Plus Chemoimmunotherapy Fails to Improve PFS in Pretreated FL, MZL
20 Jun 2023 //
ONCLIVE
Lurbinectedin/Doxorubicin Comparable to Standard of Care for SCLC, But Safer
10 Sep 2021 //
ONCLIVE
Teva to produce children`s chemo drug again
15 Nov 2019 //
FIERCE PHARMA
Pfizer scrambles to fill void after Teva stops making chemo drug
16 Oct 2019 //
FIERCE PHARMA
CASI Pharma Announces Launch of EVOMELA® (melphalan injection) in China
12 Aug 2019 //
PR NEWSWIRE
Spectrum Pharmaceuticals sells marketed drugs to Aurobindo subsidiary for up to $300M
18 Jan 2019 //
MEDCITY NEWS
Seattle Genetics Announces results of Broad ADCETRIS® (Brentuximab Vedotin)
01 Nov 2018 //
BUSINESSWIRE
Celltrion & Teva Announce FDA ODAC Recommends CT-P10 Approval
11 Oct 2018 //
BUSINESSWIRE
AbbVie, J&J’s Imbruvica fails to target in B-Cell lymphoma trial
12 Jul 2018 //
PHARMA TIMES
AbbVie Stock Drops After Disappointing Clinical Trial Update
12 Jul 2018 //
BIOSPACE
CASI Import Drug Registration Application For Evomela Accepted For Review
05 Dec 2016 //
PR NEWSWIRE
Mundipharma licenses Spectrum`s NHL treatment, picks up Japan affiliate
19 Nov 2015 //
FIERCE PHARMA ASIA
CASI Announces First Patient Dosed In Ph 2 Trial For ENMD-2076
04 Nov 2015 //
PR NEWS WIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.